Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 3 March 2024
Revised: 5 May 2024
Accepted: 10 June 2024
First Online: 15 June 2024
Declarations
:
: The study was approved by the Ethics Commission of the University Duisburg-Essen (20-9315-BO) and by the Ethics committee of the Technical University Munich (2023-30-S-SR). All study procedures were performed in compliance with relevant laws and institutional guidelines and written informed consent was obtained from all patients prior to enrollment.
: M.B. is a consultant for AstraZeneca and received personal fees from Onera B.V. S.D. declares no conflict of interest related to the topic of the article. C.S. received institutional fees for lectures, advisory tasks and/or scientific projects from AstraZeneca, Bayer, Bioprojet, Bristol Myers Squibb, Idorsia, Inspire Medical Systems, Jazz, Mementor, ResMed, Sleepiz, and Zoll. J.S. received personal fees from Inspire Medical Systems and from Neuwirth Medical Products, research grants from Sutter Medizintechnik, Löwenstein Medical, Nyxoah and Inspire Medical Systems. C.H. was a consultant for Inspire Medical Systems, received personal fees from Neuwirth Medical Products, and research grants from Sutter Medizintechnik, Löwenstein Medical, Nyxoah and Inspire Medical Systems.